|
US - Novartis AG of Switzerland was granted an option to acquire Elixir Pharmaceuticals Inc, a Cambridge-based pharmaceutical company, for an estimated USD ### mil, including up to an undisclosed amount in profit related payments.…
|
| Credit & Investment Research |
|
|